Amgen, Gilead beat Street; Dr. Reddy's relieved of ban on Mexico plant;

 @FiercePharma: EU OKs Vertex cystic fibrosis drug Kalydeco. News | Follow @FiercePharma

 @EricPFierce: Judge says no to delaying GSK's buyout of Human Genome Sciences. More | Follow @EricPFierce

>  Share of Amgen ($AMGN) and Gilead Sciences ($GILD), both jumped after they beat Wall Street expectations on earnings. Story

> A federal appeals court on has ruled for two women who developed breast cancer after taking the hormone therapy drug Prempro saying the case needs to be reviewed again by a lower court. Story

> India drugmaker Dr Reddy's Laboratories says the FDA has lifted its import alert on its Mexico-based subsidiary so that it can now begin exporting products to the U.S. from there. Story

> Drug wholesaler McKesson Corp. ($MCK) had a 33% rise in first quarter earnings, driven primarily by revenues from its pharmaceutical distribution business. Story

Medical Device News

@FierceMedDev: The WHO is vetting two circumcision devices designed to slow the spread of HIV in Africa. Story | Follow @FierceMedDev

 @MarkHFierce: Terumo seeks merger deal with Olympus. Will Olympus say yes? More | Follow @MarkHFierce

 @DamianFierce: Despite taking a loss in Q2, Sequenom is forging ahead with its Down syndrome Dx. News | Follow @DamianFierce

> Roche sells more Dx equipment, fewer diabetes products in H1 2012. Article

> Depression-treating device tests well in everyday clinical practice use. Item

Biotech News

 @FierceBiotech: Covance takes a $12.7M loss in Q2. More | Follow @FierceBiotech

 @JohnCFierce: A majority of FDA experts vote for approval of ThromboGenics' eye drug ocriplasmin. Post-OK study would be "nice." Report | Follow @JohnCFierce

 @RyanMFierce: EU approval of Vertex's Kalydeco in cystic fibrosis comes 7 months after FDA stamp. Release | Follow @RyanMFierce

> ThromboGenics wins FDA panel nod for eye drug. News

> Analysts: Ailing Elan casts buyout bait for Biogen Idec. Report

> Buzz: HGS passed up $7B Amgen bid back in the day. Story

> FDA OKs Amarin's blockbuster heart drug contender AMR101. Article

> FDA green-lights Horizon Pharma's Rayos. More

And Finally... Researcher have said that treatments appear to have cleared two men of the HIV virus, raising the possibility of a cure for the disease. Story

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.